This article was originally published in The Gray Sheet
Surgical cryoablation system will debut in July following recent 510(k) clearance received by strategic partner Endocare for treatment of cardiac arrhythmias in patients undergoing other cardiac procedures such as bypass surgery and valve replacement. The firm sees a $200 mil. market opportunity...
You may also be interested in...
CryoCath aims to place its Freezor cryoablation catheter in 300 centers by year-end, pending PMA approval of the supraventricular tachycardia treatment device
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.